Part I :
This is a review of atherogenic lipoproteins beyond just LDL. Clinicians guide to what to assess in an individual patient in front of them in the clinic.
The presentation proceeds with the Evidence based review of Statins -- the positive impact on outcomes but it highlights the limitations of Statins and sets the stage for why we need other or newer lipid powering agents.

In Part II (another video) the presentation will go through Non Statin medications to lower the atherogenic lipids: how they act, what is the efficacy and most importantly will they overcome the limitations we presently face from the Statins. What is the evidence on hard outcomes?

свернуть